We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · December 07, 2020

Effectiveness of Different Natalizumab Dosing Schedules in Multiple Sclerosis

Journal of Neurology, Neurosurgery, and Psychiatry

 

Additional Info

Journal of Neurology, Neurosurgery, and Psychiatry
Clinical Effectiveness of Different Natalizumab Interval Dosing Schedules in a Large Italian Population of Patients With Multiple Sclerosis
J. Neurol. Neurosurg. Psychiatr. 2020 Dec 01;91(12)1297-1303, CG Chisari, LM Grimaldi, G Salemi, P Ragonese, P Iaffaldano, S Bonavita, M Sparaco, M Rovaris, A D'Arma, A Lugaresi, MT Ferrò, P Grossi, A Di Sapio, E Cocco, F Granella, E Curti, V Lepore, M Trojano, F Patti

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading